Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ka-Ming Yau"'
Autor:
Yi-Ping Wong, Rowena How-Wan Wong, Zhaoxiang Bian, Chi-Fung Choy, Bacon F.L. Ng, Linda Ld Zhong, Ka-Ming Yau, Hung-Wai Cho, Alan Yat-Lun Wong
Background: Olfactory dysfunction (OD) was recognized as one of common symptom of COVID-19. OD, defined as the reduced or distorted ability to smell during sniffing (orthonasal olfaction) and may represent one of early symptoms in the clinical course
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::411a002b3125ce5d153fcbe7d5e1d193
https://doi.org/10.21203/rs.3.rs-823921/v1
https://doi.org/10.21203/rs.3.rs-823921/v1
Autor:
Nick Ka Ming Yau, Ian C. K. Wong, Qin Ying Lim, Vivian Wai Yan Lui, Krista Roberta Verhoeft, WY Lam, Andrew Yuon Fong, Hiu Fung Leung
Publikováno v:
Current Cancer Drug Targets. 15:327-336
The anaplastic lymphoma kinase (ALK) is a druggable target for cancer therapy. By and large, the oncogenic activation of ALK in human tumors is known to occur by gene rearrangement (e.g. EML4-ALK, NMP-ALK, etc.). Clinical use of ALK inhibitors for "A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f774a8ebf25865e3f7907bc1404b68b7
https://doi.org/10.2174/1568009615666150225123712
https://doi.org/10.2174/1568009615666150225123712
Autor:
Nick Ka Ming, Yau, Andrew Yuon, Fong, Hiu Fung, Leung, Krista Roberta, Verhoeft, Qin Ying, Lim, Wai Yip, Lam, Ian Chi Kei, Wong, Vivian Wai Yan, Lui
Publikováno v:
Current cancer drug targets. 15(4)
The anaplastic lymphoma kinase (ALK) is a druggable target for cancer therapy. By and large, the oncogenic activation of ALK in human tumors is known to occur by gene rearrangement (e.g. EML4-ALK, NMP-ALK, etc.). Clinical use of ALK inhibitors for "A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d57f1ff37f98d4f2c1b3633d6977e7c9
https://pubmed.ncbi.nlm.nih.gov/25714698
https://pubmed.ncbi.nlm.nih.gov/25714698
Autor:
Ka Ming Yau, Nick, Yuon Fong, Andrew, Fung Leung, Hiu, Roberta Verhoeft, Krista, Ying Lim, Qin, Yip Lam, Wai, Chi Kei Wong, Ian, Wai Yan Lui, Vivian
Publikováno v:
Current Cancer Drug Targets; May 2015, Vol. 15 Issue: 4 p327-336, 10p